With slow health benefit cost growth in 2020, employers plan to invest in more support for employees, says Mercer

Filed Under: Costs

With slow health benefit cost growth in 2020, employers plan to invest in more support for employees, says Mercer

“Total health benefit cost rose 3.4% on average in 2020, reaching $13,674 per employee among all US employer health plan sponsors with 50 or more employees, according to the annual Mercer National Survey of Employer-Sponsored Health Plans 2020,” Mercer wrote in a press release. “Large employers (those with 500 or more employees) reported a cost […]

Coronavirus (Covid-19) and vaccines: What if my employer requires me to get it?

Filed Under: Costs, Patients

Coronavirus (Covid-19) and vaccines: What if my employer requires me to get it?

As Covid vaccines reach or near approval, some Americans are wary, citing the rushed timeline as a reason to delay getting the shot. But eventually, even the dwindling number of Americans saying they don’t plan to get the injection may have to choose between abstaining from the vaccine and keeping their jobs. ClearHealthCosts spoke with […]

Coronavirus (Covid-19) and the vaccine: How it works when you volunteer for a trial of a new shot

Filed Under: Costs, Patients, Providers

Coronavirus (Covid-19) and the vaccine: How it works when you volunteer for a trial of a new shot

Julie Dunn said it was an easy choice to volunteer for the coronavirus vaccine trials run by Moderna. “I used to work on clinical trials,” Dunn said in a video interview. “I’m an epidemiologist by training, and I understand how challenging it is to recruit for trials and get a decent cross-section of people. So […]

Coronavirus (Covid-19) and autoimmune diseases: What’s the connection?

Filed Under: Costs, Patients, Providers

Coronavirus (Covid-19) and autoimmune diseases: What’s the connection?

When Julie Copaken got sick with Covid in early March, she believed it was just a bad flu. “I was achy in a way I’ve never been achy before. I had diarrhea, I had horrible headaches, I was very fatigued, like I couldn’t get out of bed fatigued,” Copaken, 48, of Jacksonville, Fla., said in […]

Coronavirus (Covid-19) and pregnancy: Women navigating the two at once

Filed Under: Costs

Coronavirus (Covid-19) and pregnancy: Women navigating the two at once

MaElena Barcenas, of Detroit, Mich., had what started out as a fairly normal pregnancy. Other than persistently high blood pressure, she said, the first seven months went smoothly for her. In mid-March, around seven months into Barcenas’s pregnancy, she began experiencing symptoms of pre-eclampsia, including extremely high blood pressure and swelling in her feet and […]

Coronavirus (Covid-19) and the brain: It’s not just a respiratory illness

Coronavirus (Covid-19) and the brain: It’s not just a respiratory illness

Ten days after testing positive for Covid and a week after her fever subsided this August, Hannah Chambers came down with new symptoms she hadn’t experienced before. “I felt a little different,” said Chambers, who is 27 and lives in Davenport, Ia. “I was still in quarantine at that time, but when I woke up […]

Coronavirus (Covid-19) and timing: U.S. covid cases found as early as December 2019, says study

Filed Under: Costs, Patients

Coronavirus (Covid-19) and timing: U.S. covid cases found as early as December 2019, says study

“Testing has found Covid-19 infections in the U.S. in December 2019, according to a study, providing further evidence indicating the coronavirus was spreading globally weeks before the first cases were reported in China,” Bloomberg News writes. “The study published Monday identified 106 infections from 7,389 blood samples collected from donors in nine U.S. states between […]

Coronavirus (Covid-19) and vaccines: The ABC’s right now

Filed Under: Costs, Patients, Providers

Coronavirus (Covid-19) and vaccines: The ABC’s right now

By JEANNE PINDER and VIRGINIA JEFFRIES Who is making the vaccines? While dozens companies and organizations are in the process of testing and manufacturing Covid vaccines, five appear poised to have their shots ready for the public in the United States within the next six months: Pfizer (in partnership with BioNTech) Moderna AstraZeneca (in partnership […]